#1Recovery Protocol
94%Actin Binding
24+Research Products
>98%Purity Verified
$200+Free Shipping
VerifiedSupplier
CLAV'S STACK 2026

Clavicular's Recovery Peptides

Retatrutide drives the fat loss. TB-500 and BPC-157 handle the recovery — protecting lean mass and the GI system during aggressive caloric restriction. This is the recovery side of Clavicular's looksmaxxing protocol.

≥98% Purity HPLC Tested Free Ship $200+

How Clavicular's Stack Is Structured

Clav runs a two-layer protocol — a potent fat loss agonist paired with recovery peptides that keep the body functional during the cut.

Layer 1 — Fat Loss

Retatrutide (Triple Agonist)

GLP-1 + GIP + Glucagon receptor agonist. −24.2% mean weight reduction in Phase 2 trials. The core of Clav's shred — available on sites specialising in GLP-1/GIP/glucagon peptides.

Not sold here — see clavtides.com or peptideslooksmaxxing.com

Layer 2 — Recovery (This Site)

TB-500 + BPC-157

TB-500 for lean mass preservation and satellite cell activation. BPC-157 for GI cytoprotection — counteracting Retatrutide's nausea and gastroparesis side effects. Both available here, research grade.

Buy TB-500

Why TB-500 + BPC-157 in Clav's Protocol

TB-500 — Lean Mass Preservation

Retatrutide's caloric restriction creates a catabolic environment. TB-500 (synthetic Thymosin Beta-4 fragment) activates satellite cells — the muscle stem cells responsible for repair and hypertrophy. Its actin-sequestering Ac-LKKTETQ motif promotes cell migration and tissue repair while its anti-inflammatory properties reduce TNF-α and IL-1β. Research rationale: protecting lean mass during aggressive fat loss.

Satellite cell activation → lean mass protection
G-actin sequestration → tissue repair signalling
Anti-inflammatory: ↓ TNF-α, ↓ IL-1β
VEGF upregulation → angiogenesis support

BPC-157 — GI Shield

Retatrutide's GLP-1 component causes nausea and delayed gastric emptying — especially during dose titration. BPC-157 (pentadecapeptide 137525-51-0) is gastric juice-derived and exerts cytoprotective effects via nitric oxide upregulation, tight junction protein restoration, and VEGFR2-mediated mucosal repair. Research rationale: counteracting the GI side effects that accompany GLP-1 agonist protocols.

Nitric oxide ↑ → gastroprotection + vasodilation
Tight junction restoration → gut barrier integrity
VEGFR2 → mucosal angiogenesis and repair
NF-κB suppression → GI anti-inflammation

Buy Clav's Recovery Peptides

Research-grade, ≥98% purity, HPLC verified. All products supplied as lyophilized powder.

Core Recovery Stack

Clav's Recovery Pick

TB500 10mg

Thymosin Beta-4 fragment — satellite cell activation, actin dynamics, anti-inflammatory signalling.

$59.99

Buy TB-500
Clav's GI Shield

BPC157 10mg

Pentadecapeptide — GI cytoprotection, nitric oxide, VEGFR2 tissue repair. Counteracts GLP-1 nausea.

$59.99

Buy BPC-157

Extended Protocol Additions

Clavicular's Protocol: Research Reference

PeptideRole in StackMechanismAvailable Here
RetatrutidePrimary fat loss agonistGLP-1 + GIP + Glucagon receptorNo — see clavtides.com
TB-500Lean mass + repairActin sequestration, satellite cells✓ Yes
BPC-157GI shield + cytoprotectionNO pathway, VEGFR2, tight junctions✓ Yes
IGF-1 LR3Anabolic support (optional)mTOR, satellite cell activation✓ Yes
CJC/IpaGH secretagogue (optional)GHRH-R + GHSR-1a synergy✓ Yes

FAQ

What peptides does Clavicular use?

Clavicular's looksmaxxing stack is built around Retatrutide (triple GLP-1/GIP/glucagon agonist) for fat loss, paired with TB-500 (thymosin beta-4 fragment) and BPC-157 for recovery and GI cytoprotection during aggressive caloric restriction. Some extended protocols also include CJC-1295/Ipamorelin for GH pulse support and IGF-1 LR3 for lean mass.

Why does Clavicular pair TB-500 with Retatrutide?

Retatrutide induces significant caloric restriction — a catabolic environment where lean mass is at risk. TB-500's satellite cell activation and anti-catabolic properties in animal models provide a mechanistic rationale for preserving muscle tissue during the cut. Its anti-inflammatory properties also support overall recovery.

Why does Clavicular use BPC-157 in his stack?

GLP-1 receptor agonism (Retatrutide's primary fat loss mechanism) causes nausea, vomiting, and delayed gastric emptying — especially during dose titration. BPC-157's gastroprotective mechanisms — nitric oxide production, tight junction restoration, VEGFR2-mediated mucosal repair — directly address these GI side effects, allowing the titration to proceed more smoothly.

Where can I buy Clavicular's exact recovery stack?

TB-500, BPC-157, IGF-1 LR3, and CJC-1295/Ipamorelin are all available here at PeptideTB500 from our trusted research supplier — ≥98% purity, HPLC verified, lyophilized powder for laboratory research. Retatrutide (the primary fat loss agonist) is available at clavtides.com or peptideslooksmaxxing.com.

Research Use Only. All products are for in-vitro laboratory research only. Not for human consumption, injection, or therapeutic use. Not medical advice.